Diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inpatients with diabetes at Diabetes Center, Ohta Nishinouchi Hospital in whom new treatment is started with insulin, GLP-1 receptor agonist injectable medication, or both.
Exclusion criteria
Exclusion criteria: 1. Patients from whom consent for the questionnaire survey is not obtained 2. Patients with the following in whom self-injection is judged to be difficult Patients for whom insulin, GLP-1 receptor agonists, or both are contraindicated, patients with upper limb loss/amputation, contracture, neuropathy, past arthroplasty, arthritis, joint deformity, history of severe functional disorder, or concurrent dementia or psychiatric disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Little anxiety, such as needle piercing, skin damage 2. Ease of use from attachment to removal 3. Needle I want to use from now on | — |
Countries
Japan
Contacts
Ohta Nishinouchi Hospital Pharmaceutical department